Monday, April 17, 2017
Xencor Names New Board Member
Monrovia-based biopharmaceuticals developer Xencor announced this morning that it has named Kevin Gorman, ph.D., to its board of directors. Gorman is the CEO of Neurocrine Biosciences, where he has been since 1993; he previously was an investor at Avalon Medical Partners, L.P. Gorman replaces director Robert Baltera, Jr., who the company said will not stand for re-election to its board.
Get More SocalTech Data
Try our two week free trial to find new tech customers, find high tech startups and jobs, find venture funding, and more!Learn More